Ignite Creation Date:
2024-05-06 @ 1:39 AM
Last Modification Date:
2024-10-26 @ 11:07 AM
Study NCT ID:
NCT01864746
Status:
COMPLETED
Last Update Posted:
2023-12-12
First Post:
2013-05-14
Brief Title:
A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery
Sponsor:
German Breast Group
Organization:
German Breast Group
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Cancer |
| Hormonreceptor Positive |
| Her2-normal |
| Postneoadjuvant Treatment With CDK 46 Inhibitor |
| CPS-EG Score |
Keywords: